Johns Hopkins HIV Guide
Telaprevir
INDICATIONS
FDA
FDA
No longer available in the U.S.
- In combination with peg-interferon and ribavirin, telaprevir indicated for the treatment of HCV (genotype1) patients with compensated liver disease, including cirrhosis, who are treatment-naïve OR who have been previously treated with interferon-based regimen, but had no response, partial response, or relapsed
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 14, 2026
Citation
Soto, Caitlin, and Janessa Smith. "Telaprevir." Johns Hopkins HIV Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545231/all/Telaprevir.
Soto C, Smith J. Telaprevir. Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545231/all/Telaprevir. Accessed October 22, 2026.
Soto, C., & Smith, J. (2026). Telaprevir. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545231/all/Telaprevir
Soto C, Smith J. Telaprevir [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. [cited 2026 October 22]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545231/all/Telaprevir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Telaprevir
ID - 545231
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Smith,Janessa,Pharm.D. BCPS
Y1 - 2026/10/14/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545231/all/Telaprevir
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
